The stock opened at Rs 3,097 and touched a low of Rs 3,047 on NSE. Till 1221 hours, a combined 107,884 shares changed hands as against an average sub 50,000 shares that were traded daily in past two weeks on NSE and BSE.
A stock split, or sub-division of equity shares, is done to infuse liquidity and to make shares affordable for retail investors who could not invest earlier because of the high stock price.
In past one year, the stock has zoomed 223% from Rs 998 compared with 34% rise in CNX Nifty.
Earlier, in August 2012, the pharmaceutical company had sub-divided face value of its equity shares to Rs 5 from Rs 10. Since then, the stock has appreciated by more than 10-fold from Rs 251 (adjusted to stock split and bonus shares) against 64% surge in benchmark index.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app